175 related articles for article (PubMed ID: 3704554)
1. Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy.
Møller-Petersen J; Schmidt EB
Scand J Haematol; 1986 Mar; 36(3):295-301. PubMed ID: 3704554
[TBL] [Abstract][Full Text] [Related]
2. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous analysis of serum immunoglobulins in patients with M protein using cellulose acetate membrane isoelectric focusing.
Iijima S; Shiba K; Kurihara Y; Kamei S; Kimura S; Kimura M; Fukumura Y; Kobayashi I
J Clin Lab Anal; 1999; 13(4):145-50. PubMed ID: 10414593
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy in general practice. Diagnostic value of typing and quantitation of immunoglobulins.
Schmidt EB; Møller-Petersen J
Scand J Prim Health Care; 1985 May; 3(2):91-4. PubMed ID: 3933073
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
[TBL] [Abstract][Full Text] [Related]
6. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.
Gregersen H; Mellemkjaer L; Ibsen JS; Dahlerup JF; Thomassen L; Sørensen HT
Haematologica; 2001 Nov; 86(11):1172-9. PubMed ID: 11694403
[TBL] [Abstract][Full Text] [Related]
7. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
Fisher MA; Wilson JR
Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
[TBL] [Abstract][Full Text] [Related]
8. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
Anagnostopoulos A; Galani E; Gika D; Sotou D; Evangelopoulou A; Dimopoulos MA
Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
[TBL] [Abstract][Full Text] [Related]
11. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
Mehndiratta MM; Sen K; Tatke M; Bajaj BK
J Neurol Sci; 2004 Jun; 221(1-2):99-104. PubMed ID: 15178222
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of serum IgM and IgA monoclonal protein measurements by densitometry.
Tseng CH; Chang CY; Liu KS; Liu FJ
Ann Clin Lab Sci; 2003; 33(2):160-6. PubMed ID: 12817620
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathies of undetermined significance: a review.
Kyle RA; Rajkumar SV
Immunol Rev; 2003 Aug; 194():112-39. PubMed ID: 12846812
[TBL] [Abstract][Full Text] [Related]
14. Neuropathies associated with IgG and IgA monoclonal gammopathy.
Nobile-Orazio E; Casellato C; Di Troia A
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):979-87. PubMed ID: 12407307
[TBL] [Abstract][Full Text] [Related]
15. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal gammopathies of undetermined significance].
Ifrah N; Zandecki M
Rev Prat; 2006 Jan; 56(1):18-24. PubMed ID: 16548245
[TBL] [Abstract][Full Text] [Related]
17. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
[TBL] [Abstract][Full Text] [Related]
18. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance?
Brigden ML
Postgrad Med; 1999 Aug; 106(2):135-42; quiz 185. PubMed ID: 10456045
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Offord JR; Dispenzieri A; Katzmann JA; Melton LJ
N Engl J Med; 2006 Mar; 354(13):1362-9. PubMed ID: 16571879
[TBL] [Abstract][Full Text] [Related]
20. Serum markers in the differential diagnosis of Waldenstrom macroglobulinemia and other IgM monoclonal gammopathies.
Zou H; Yang R; Liao ZX; Qin TD; Chen P; Zhang BY; Cao YP; Huang HF
J Clin Lab Anal; 2019 Mar; 33(3):e22827. PubMed ID: 30485557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]